FULL SUPPLEMENT: United States Cutaneous Oncodermatology Management (USCOM ) V: A Multidisciplinary-Guided Algorithm for Preventing and Managing Cutaneous Hormonal Therapy-Related Adverse Events in Cancer Patients

Although cancer incidence continues to rise, advancements in treatment options have contributed to the decline in cancer mortality.1,3 Hormonal therapy is a mainstay treatment for the management of hormone-dependent cancers. In breast cancer, hormonal therapy often involves reducing estrogen levels or blocking estrogen receptors. For prostate cancer, therapy typically aims to lower testosterone levels or block its effects through androgen deprivation therapy or antiandrogens.